Home/Filings/4/0001562180-25-000269
4//SEC Filing

Obenshain Andrew 4

Accession 0001562180-25-000269

CIK 0001293971other

Filed

Jan 7, 7:00 PM ET

Accepted

Jan 8, 4:06 PM ET

Size

8.5 KB

Accession

0001562180-25-000269

Insider Transaction Report

Form 4
Period: 2025-01-06
Obenshain Andrew
DirectorPresident and CEO
Transactions
  • Sale

    Common Stock

    2025-01-06$9.24/sh140$1,29418,571 total
Footnotes (2)
  • [F1]Shares were sold to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
  • [F2]The number of securities reported herein have been adjusted to reflect a 1-for-20 reverse stock split effected by the Issuer on December 12, 2024.

Issuer

bluebird bio, Inc.

CIK 0001293971

Entity typeother

Related Parties

1
  • filerCIK 0001839697

Filing Metadata

Form type
4
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 4:06 PM ET
Size
8.5 KB